Top compounds associated with response to PRAMEF18


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC -0.033 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA alisertib CTRPv2 pan-cancer AAC -0.028 0.4
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC -0.033 0.4
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA MG-132 CTRPv2 pan-cancer AAC -0.053 0.4
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.037 0.4
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.032 0.4
mRNA austocystin d CTRPv2 pan-cancer AAC -0.031 0.4
mRNA narciclasine CTRPv2 pan-cancer AAC -0.028 0.4
Download CSV